Amylyx Pharmaceuticals
Signal active
Organization
Contact Information
Overview
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain. The company features a drug designed to prevent nerve cell death and degeneration.
About
Industries
Biotechnology, Pharmaceutical, Medical, Neuroscience
Founded
2014
Employees
251-500
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Amylyx Pharmaceuticals headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical, Medical, Neuroscience sector. The company focuses on Biotechnology and has secured $57.4B in funding across 128 round(s). With a team of 251-500 employees, Amylyx Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Amylyx Pharmaceuticals, raised $1.4M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
8
Investors
0
Lead Investors
0
Total Funding Amount
$448.5M
Details
5
Amylyx Pharmaceuticals has raised a total of $448.5M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Late Stage Venture | 135.0M | ||
| 2016 | Early Stage Venture | 5.0M | ||
| 2016 | Seed | 3.0M | ||
| 2015 | Seed | 1.4M |
Investors
Amylyx Pharmaceuticals is funded by 29 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Amylyx Pharmaceuticals | - | FUNDING ROUND - Amylyx Pharmaceuticals | 5.0M |
| Lysosomal Therapeutics | - | FUNDING ROUND - Lysosomal Therapeutics | 5.0M |
| The ALS Association | - | FUNDING ROUND - The ALS Association | 3.0M |
| Amylyx Pharmaceuticals | - | FUNDING ROUND - Amylyx Pharmaceuticals | 3.0M |
Recent Activity
There is no recent news or activity for this profile.